ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PGEN Precigen Inc

1,32
0,00 (0,00%)
19 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Precigen Inc PGEN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,32 23:21:45
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,30 1,28 1,34 1,33 1,32
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
28.3.202421:05PRNUSPrecigen and Recurrent Respiratory Papillomatosis Foundation..
19.3.202421:05PRNUSPrecigen Reports Full Year 2023 Financial Results and..
19.3.202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
12.3.202421:05PRNUSPrecigen to Participate in a Fireside Chat Hosted by Cantor..
05.3.202422:05PRNUSPrecigen to Announce Fourth Quarter and Full Year 2023..
27.2.202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202421:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202422:25EDGAR2Form 8-K - Current report
06.2.202422:05PRNUSPrecigen to Participate in the Oppenheimer 34th Annual..
18.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16.1.202414:05PRNUSPrecigen Receives Orphan Drug Designation for PRGN-2012 for..
08.1.202414:39EDGAR2Form 8-K - Current report
08.1.202414:30PRNUSPrecigen Highlights Pipeline Updates to be Presented at the..
29.12.202323:26EDGAR2Form S-3 - Registration statement under Securities Act of..
18.12.202322:05PRNUSPrecigen to Present at the 42nd Annual J.P. Morgan..
29.11.202322:05PRNUSPrecigen to Participate in the JMP Securities Hematology and..
09.11.202323:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202323:07EDGAR2Form 8-K - Current report
09.11.202322:55PRNUSPrecigen Reports Third Quarter 2023 Financial Results and..
07.11.202322:05PRNUSPrecigen to Participate in the Stifel 2023 Healthcare..
19.9.202322:05PRNUSPrecigen to Participate in Upcoming Leading Investor and..
26.8.202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202300:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202303:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202303:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202303:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.8.202303:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.8.202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.8.202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.8.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.8.202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.8.202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.8.202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202314:15EDGAR2Form 8-K - Current report
09.8.202314:00PRNUSPrecigen Reports Second Quarter and First Half 2023..
09.8.202313:05PRNUSPrecigen Announces FDA Confirmation that the Ongoing Phase..
05.8.202301:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.8.202301:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.8.202301:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.8.202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.8.202301:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:05PRNUSPrecigen to Announce Second Quarter and First Half 2023..
06.7.202323:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
20.6.202314:21DJNPrecigen Gets FDA Breakthrough Therapy Designation for..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock